<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35178647</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1434-9949</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical rheumatology</Title>
          <ISOAbbreviation>Clin Rheumatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chronic kidney disease in Korean patients with lupus nephritis: over a 35-year period at a single center.</ArticleTitle>
        <Pagination>
          <StartPage>1665</StartPage>
          <EndPage>1674</EndPage>
          <MedlinePgn>1665-1674</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-021-06030-w</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Chronic kidney disease (CKD) is a major risk factor for overall morbidity and mortality even in lupus nephritis (LN) patients. However, less attention has been paid to the development of CKD in patients with LN. The objective of this study was to identify predictors for CKD with 35-year experience depending on newly revised guidelines for patients with LN.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study for 401 patients who visited Seoul St. Mary's Hospital between January 1985 and December 2019. We analyzed clinical and laboratory indices, treatment response, the final renal function, and biopsy findings. The timing and cumulative risk of developing CKD were identified by Kaplan-Meier methods. Independent risk factors for developing CKD were examined by Cox proportional hazard regression analyses.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The median follow-up time after the diagnosis of LN was 131 months. CKD occurred in 15.5% of patients within 10 years after the diagnosis of LN. The development of CKD was associated with delayed-onset LN, acute renal dysfunction at onset of LN, and failure to reach complete response (CR) at 6 or 12 months rather than histopathological findings or the severity of proteinuria at onset of LN. Cumulative incidence of progression to CKD was significantly higher in patients with the three predictors mentioned above.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ten-year cumulative incidence of CKD was about 15%. Our results showed that delayed-onset LN, acute renal dysfunction at the onset of LN, and inadequate treatment response assessed at 6 or 12 months after treatment were predictors for the development of CKD in LN. Key Points • CKD is a major risk factor for overall morbidity and mortality in LN patients. • Ten-year cumulative incidence of CKD was about 15% • Delayed-onset LN, acute renal dysfunction at the onset of LN, and inadequate treatment response assessed at 6 or 12 months after treatment were predictors for the development of CKD in LN.</AbstractText>
          <CopyrightInformation>© 2022. International League of Associations for Rheumatology (ILAR).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jeon</LastName>
            <ForeName>Howook</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Cheonbo-ro, 271, Uijeongbu-si, Gyeonggi-do, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ju</LastName>
            <ForeName>Ji Hyeon</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Wan-Uk</ForeName>
            <Initials>WU</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Sung-Hwan</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moon</LastName>
            <ForeName>Su-Jin</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Cheonbo-ro, 271, Uijeongbu-si, Gyeonggi-do, Republic of Korea. prajna79@catholic.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwok</LastName>
            <ForeName>Seung-Ki</ForeName>
            <Initials>SK</Initials>
            <Identifier Source="ORCID">0000-0002-6142-8364</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea. seungki73@catholic.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Clin Rheumatol</MedlineTA>
        <NlmUniqueID>8211469</NlmUniqueID>
        <ISSNLinking>0770-3198</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic kidney disease</Keyword>
        <Keyword MajorTopicYN="N">Lupus nephritis</Keyword>
        <Keyword MajorTopicYN="N">Predictors</Keyword>
        <Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
          <Hour>5</Hour>
          <Minute>53</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35178647</ArticleId>
        <ArticleId IdType="doi">10.1007/s10067-021-06030-w</ArticleId>
        <ArticleId IdType="pii">10.1007/s10067-021-06030-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME (2012) Lupus nephritis: a critical review. Autoimmun Rev 12:174–194. https://doi.org/10.1016/j.autrev.2012.08.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2012.08.018</ArticleId>
            <ArticleId IdType="pubmed">22982174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sterner RM, Hartono SP, Grande JP (2014) The pathogenesis of lupus nephritis. J Clin Cell Immunol 5:205. https://doi.org/10.4172/2155-9899.1000205</Citation>
        </Reference>
        <Reference>
          <Citation>Stenvinkel P (2010) Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 268:456–467. https://doi.org/10.1111/j.1365-2796.2010.02269.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2796.2010.02269.x</ArticleId>
            <ArticleId IdType="pubmed">20809922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mageau A, Timsit JF, Perrozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Sacre K (2019) The burden of chronic kidney disease in systemic lupus erythematosus: a nationwide epidemiologic study. Autoimmun Rev 18:733–737. https://doi.org/10.1016/j.autrev.2019.05.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2019.05.011</ArticleId>
            <ArticleId IdType="pubmed">31059847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon SJ, Kwok SK, Ju JH, Park KS, Park SH, Cho CS, Kim HY (2011) Predictors of chronic kidney disease in Korean patients with lupus nephritis. J Rheumatol 38:2588–2597. https://doi.org/10.3899/jrheum.110363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3899/jrheum.110363</ArticleId>
            <ArticleId IdType="pubmed">21965650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR (2011) Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int 79:914–920. https://doi.org/10.1038/ki.2010.525</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2010.525</ArticleId>
            <ArticleId IdType="pubmed">21248713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parikh SV, Nagaraja HN, Hebert L, Rovin BH (2014) Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol 9:279–284. https://doi.org/10.2215/cjn.05040513</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2215/cjn.05040513</ArticleId>
            <ArticleId IdType="pubmed">24262502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pokroy-Shapira E, Gelernter I, Molad Y (2014) Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study. Clin Rheumatol 33:649–657. https://doi.org/10.1007/s10067-014-2527-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-014-2527-0</ArticleId>
            <ArticleId IdType="pubmed">24535410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sui M, Ye X, Ma J, Yu C, Zhao S, Liu X, Li L, Cao J, Jia X, Xie R (2015) Epidemiology and risk factors for chronic kidney disease in Chinese patients with biopsy-proven lupus nephritis. Intern Med J 45:1167–1172. https://doi.org/10.1111/imj.12840</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imj.12840</ArticleId>
            <ArticleId IdType="pubmed">26109241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park DJ, Kang JH, Lee JW, Lee KE, Kim TJ, Park YW, Lee JS, Choi YD, Lee SS (2017) Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis. Lupus 26:1139–1148. https://doi.org/10.1177/0961203317694257</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0961203317694257</ArticleId>
            <ArticleId IdType="pubmed">28420060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroni G, Gatto M, Tamborini F, Quaglini S, Radice F, Saccon F, Frontini G, Alberici F, Sacchi L, Binda V, Trezzi B, Vaglio A, Messa P, Sinico RA, Doria A (2020) Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis. Ann Rheum Dis 79:1077–1083. https://doi.org/10.1136/annrheumdis-2020-216965</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2020-216965</ArticleId>
            <ArticleId IdType="pubmed">32503858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782. https://doi.org/10.1136/annrheumdis-2012-201940</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2012-201940</ArticleId>
            <ArticleId IdType="pubmed">22851469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT (2020) 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79:713–723. https://doi.org/10.1136/annrheumdis-2020-216924</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2020-216924</ArticleId>
            <ArticleId IdType="pubmed">32220834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/art.1780400928</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.1780400928</ArticleId>
            <ArticleId IdType="pubmed">9324032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1523-1755.2005.00365.x</ArticleId>
            <ArticleId IdType="pubmed">15882252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Churg J, Sobin LH (1982) Renal disease classification and atlas of glomerular disease. Igaku-Shoin, Tokyo</Citation>
        </Reference>
        <Reference>
          <Citation>Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530. https://doi.org/10.1111/j.1523-1755.2004.00443.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1523-1755.2004.00443.x</ArticleId>
            <ArticleId IdType="pubmed">14717922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391. https://doi.org/10.1016/0002-9343(83)90338-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9343(83)90338-8</ArticleId>
            <ArticleId IdType="pubmed">6351607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faurschou M, Starklint H, Halberg P, Jacobsen S (2006) Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 33:1563–1569</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16881113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faurschou M, Dreyer L, Kamper AL, Starklint H, Jacobsen S (2010) Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) 62:873–880. https://doi.org/10.1002/acr.20116</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.20116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costenbader KH, Desai A, Alarcón GS, Hiraki LT, Shaykevich T, Brookhart MA, Massarotti E, Lu B, Solomon DH, Winkelmayer WC (2011) Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum 63:1681–1688. https://doi.org/10.1002/art.30293</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.30293</ArticleId>
            <ArticleId IdType="pubmed">21445962</ArticleId>
            <ArticleId IdType="pmc">3106117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pakchotanon R, Gladman DD, Su J, Urowitz MB (2018) Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis. Lupus 27:468–474. https://doi.org/10.1177/0961203317726376</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0961203317726376</ArticleId>
            <ArticleId IdType="pubmed">28857717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naiker IP, Chrystal V, Randeree IG, Seedat YK (1997) The significance of arterial hypertension at the onset of clinical lupus nephritis. Postgrad Med J 73:230–233. https://doi.org/10.1136/pgmj.73.858.230</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/pgmj.73.858.230</ArticleId>
            <ArticleId IdType="pubmed">9156126</ArticleId>
            <ArticleId IdType="pmc">2431293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunha C, Alexander S, Ashby D, Lee J, Chusney G, Cairns TD, Lightstone L (2018) Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome? Nephrol Dial Transplant 33:1604–1610. https://doi.org/10.1093/ndt/gfx318</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ndt/gfx318</ArticleId>
            <ArticleId IdType="pubmed">29186572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu CY, Tan M, Huang JY, Chiou JY, Wei JC (2020) Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217728</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2020-217728</ArticleId>
            <ArticleId IdType="pubmed">33109602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park DJ, Choi SE, Xu H, Kang JH, Lee JS, Choi YD, Lee SS (2021) Uric acid as a risk factor for progression to chronic kidney disease in patients with lupus nephritis: results from the KORNET registry. Clin Exp Rheumatol 39:947–954</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
